Development and Applications of Photoinducible Bioorthogonal Chemistry

光诱导生物正交化学的发展及应用

基本信息

  • 批准号:
    8240114
  • 负责人:
  • 金额:
    $ 29.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-01 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

Development and Applications of Photoinducible Bioorthogonal Chemistry ABSTRACT Bioorthogonal chemistry has emerged as a powerful tool in probing biomolecular structure and function in living systems. Combining with recent developments in introducing novel chemical reactivity into biomolecules site- selectively in vivo, bioorthogonal chemistry offers an unprecedented opportunity to monitor and expand biomolecular function in living systems. Our long term goal is to develop a toolbox of photoinducible bioorthogonal reactions and apply them to study protein function in living systems. The bioorthogonal reactions we are developing build from our chemical insights into unusual heterocycles which are thermodynamically stable, and yet undergo rapid photoinduced ring openings to generate the highly reactive intermediates. These intermediates then react selectively with their cognate, externally introduced partners in living systems. In the Preliminary Studies, we show the first photoinducible bioorthogonal reaction between diaryltetrazoles and alkenes, and its application in the site-specific modification of proteins both in biological buffer and in living E. coli cells. In this project, we propose to significantly expand the scope and the utility of this reaction toolbox by: 1) identifying tetrazoles with enhanced reactivity toward unactivated alkenes; 2) developing a photoinducible diarylazirine-based bioorthogonal reaction; 3) developing a general strategy for functionalizing newly synthesized proteins in living cells; and 4) probing protein posttranslational modifications such as lipidation and phosphorylation in living cells. We hope these new developments will enable functional study of proteins in vivo with exquisite specificity at the molecular level and operational simplicity at the system level. Our specific aims are the follows: (1) To optimize the reactivity of tetrazoles and develop a diarylazirine- based photoinducible bioorthogonal reaction. Substituent effect based on a "push-pull" hypothesis will be explored to achieve the selective and enhanced reactivity toward unactivated alkenes. (2) To develop a general strategy for labeling newly synthesized proteins in mammalian cells through co-translational alkene incorporation followed by selective functionalization with the tetrazole-based chemistry. Experiments are proposed to examine the co-translational activities of several activated alkene amino acids and their subsequent functionalization by the tetrazole compounds. (3) To apply the tetrazole-based bioorthogonal chemistry to model Ras lipidation in living cells and probe the role of lipid structures on Ras membrane targeting dynamics, specificity, and function. Both the intein-mediated chemical ligation and the amber codon suppression methods will be employed in constructing the tetrazole-encoded N-Ras mutant for this study. (4) To apply the tetrazole-based bioorthogonal chemistry to mimic STAT-1 tyrosine phosphorylation by incorporating a tetrazole amino acid at the tyrosine phosphorylation site (Tyr-701) using both native chemical ligation and amber codon suppression techniques. We will examine the effect of chemical phosphorylation on the engineered STAT-1 dimerization, nuclear transport, and transcriptional activation in living cells.
光诱导生物正交化学的发展与应用

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Qing Lin其他文献

Qing Lin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Qing Lin', 18)}}的其他基金

Development of Orally Administered Peptide Hormones for Treatment of Diabetes and Obesity
用于治疗糖尿病和肥胖症的口服肽激素的开发
  • 批准号:
    10323876
  • 财政年份:
    2021
  • 资助金额:
    $ 29.42万
  • 项目类别:
Development and Applications of Bioorthogonal Chemistry
生物正交化学的发展与应用
  • 批准号:
    10543732
  • 财政年份:
    2019
  • 资助金额:
    $ 29.42万
  • 项目类别:
Development and Applications of Bioorthogonal Chemistry: Administrative Supplement for Equipment
生物正交化学的发展与应用:设备管理补充
  • 批准号:
    10581256
  • 财政年份:
    2019
  • 资助金额:
    $ 29.42万
  • 项目类别:
Development and Applications of Bioorthogonal Chemistry
生物正交化学的发展与应用
  • 批准号:
    10317075
  • 财政年份:
    2019
  • 资助金额:
    $ 29.42万
  • 项目类别:
Development and Applications of Bioorthogonal Chemistry
生物正交化学的发展与应用
  • 批准号:
    8913203
  • 财政年份:
    2009
  • 资助金额:
    $ 29.42万
  • 项目类别:
Development and Applications of Photoinducible Bioorthogonal Chemistry
光诱导生物正交化学的发展及应用
  • 批准号:
    8460102
  • 财政年份:
    2009
  • 资助金额:
    $ 29.42万
  • 项目类别:
Development and Applications of Bioorthogonal Chemistry
生物正交化学的发展与应用
  • 批准号:
    9309042
  • 财政年份:
    2009
  • 资助金额:
    $ 29.42万
  • 项目类别:
Development and Applications of Photoinducible Bioorthogonal Chemistry
光诱导生物正交化学的发展及应用
  • 批准号:
    7793428
  • 财政年份:
    2009
  • 资助金额:
    $ 29.42万
  • 项目类别:
Development and Applications of Bioorthogonal Chemistry
生物正交化学的发展与应用
  • 批准号:
    9266090
  • 财政年份:
    2009
  • 资助金额:
    $ 29.42万
  • 项目类别:
Development and Applications of Photoinducible Bioorthogonal Chemistry
光诱导生物正交化学的发展及应用
  • 批准号:
    8055023
  • 财政年份:
    2009
  • 资助金额:
    $ 29.42万
  • 项目类别:

相似海外基金

Bifunctional Catalysts for MHAT Hydrofunctionalization of Alkenes
用于烯烃 MHAT 加氢官能化的双功能催化剂
  • 批准号:
    2400341
  • 财政年份:
    2024
  • 资助金额:
    $ 29.42万
  • 项目类别:
    Continuing Grant
Environmentally Benign Precise Transformations of Alkenes by Chiral Chalcogenide Catalysts
手性硫属化物催化剂对环境无害的烯烃精确转化
  • 批准号:
    22KJ2498
  • 财政年份:
    2023
  • 资助金额:
    $ 29.42万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
electrochemical dication pool: a new strategy to couple alkenes and abundant nucleophiles
电化学双阳离子池:偶联烯烃和丰富亲核试剂的新策略
  • 批准号:
    10635132
  • 财政年份:
    2023
  • 资助金额:
    $ 29.42万
  • 项目类别:
Development of Remote Bismetalation Reaction of Alkenes via Chain Walking
链式行走烯烃远程双金属化反应的进展
  • 批准号:
    22KJ2699
  • 财政年份:
    2023
  • 资助金额:
    $ 29.42万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Connective Stereospecific Generation of Alkenes Continued
烯烃的连接立体定向生成(续)
  • 批准号:
    2247031
  • 财政年份:
    2023
  • 资助金额:
    $ 29.42万
  • 项目类别:
    Standard Grant
Expanding the small molecule toolbox through novel applications of fluorinated alkenes
通过氟化烯烃的新颖应用扩展小分子工具箱
  • 批准号:
    10714822
  • 财政年份:
    2023
  • 资助金额:
    $ 29.42万
  • 项目类别:
Methods for Enantioselective Spirocycle Synthesis and Radical Hydroamination of Trisubstituted Alkenes
三取代烯烃的对映选择性螺环合成和自由基氢胺化方法
  • 批准号:
    10785901
  • 财政年份:
    2023
  • 资助金额:
    $ 29.42万
  • 项目类别:
Ruthenium-catalyzed hydrophosphination of alkenes
钌催化的烯烃氢膦酸化
  • 批准号:
    575021-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 29.42万
  • 项目类别:
    University Undergraduate Student Research Awards
New Catalytic Transformations for the Synthesis of Alkenes and Organoboron Compounds
烯烃和有机硼化合物合成的新催化转化
  • 批准号:
    2102231
  • 财政年份:
    2021
  • 资助金额:
    $ 29.42万
  • 项目类别:
    Continuing Grant
Development of Enantioselective Carboalumination of Alkenes and Alkynes Catalyzed by Rare-Erath Metal Catalysts
稀土金属催化剂催化烯烃和炔烃对映选择性碳铝化反应的研究进展
  • 批准号:
    21F21334
  • 财政年份:
    2021
  • 资助金额:
    $ 29.42万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了